by RGHI | Feb 27, 2021 | News
Following the FDA’s emergency approval of Johnson & Johnson’s COVID-19 vaccine, ROI-NJ published a collection of health experts’ perspectives that includes institute director Richard Marlink’s comments about vaccine efficacy.
by RGHI | Feb 25, 2021 | News
The dashboard, which displays information to help state residents, stakeholders, and policy makers understand the range of services available to youth and families, comes at a critical time. The pandemic continues to impact children and youth, who face increased levels of anxiety, stress, isolation, and a sense of loss and grief.
by RGHI | Feb 10, 2021 | News
In an interview for WRSU Rutgers Radio, institute director Richard Marlink offers perspective on the importance of a global response to COVID-19, vaccine infrastructure in Africa, vaccine production and safety, and the World Health Organization.
by Lara De Meo Hoyt | Feb 3, 2021 | News
The importance of a global COVID-19 vaccination strategy and how WHO involvement benefits the U.S. overall are topics that institute director Richard Marlink discusses in this Q&A.
by RGHI | Feb 2, 2021 | News
Appearing on CNBC’s Power Lunch, core faculty member and Rutgers vice chancellor Reynold Panettieri discusses the Johnson & Johnson COVID-19 vaccine, infection rates and hospitalizations, and effective public health measures.